lucitanib   Click here for help

GtoPdb Ligand ID: 7649

Synonyms: E-3810 amine | E3810
PDB Ligand
Compound class: Synthetic organic
Comment: Lucitanib is an inhibitor of multiple receptor tyrosine kinases [2] that was investigated for anti-angiogenic and anti-tumourigenic efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 95.7
Molecular weight 443.18
XLogP 3.6
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
Isomeric SMILES CNC(=O)c1cccc2c1ccc(c2)Oc1ccnc2c1cc(OC)c(c2)OCC1(N)CC1
InChI InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)
InChI Key CUDVHEFYRIWYQD-UHFFFAOYSA-N
References
1. Miao ZH, Feng JM, Ding J. (2012)
Newly discovered angiogenesis inhibitors and their mechanisms of action.
Acta Pharmacol Sin, 33 (9): 1103-11. [PMID:22922347]
2. Zhou Y, Chen Y, Tong L, Xie H, Wen W, Zhang J, Xi Y, Shen Y, Geng M, Wang Y et al.. (2012)
AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR.
J Cell Mol Med, 16 (10): 2321-30. [PMID:22304225]